semaglutide fda approval mash of for - Other Promisiong Pipelines Ahead FDA Approves Semaglutide (Wegovy) Injection

Research has linked rapid weight loss, particularly that facilitated by GLP-1s like Wegovy and Mounjaro to an increased risk of gallstones

Graf M.V., et al

the drugs work by modulating appetite, regulating blood sugar, and slowing gastric emptying

The combination of sustained weight loss, improved metabolic markers, and enhanced quality of life makes GLP-1 injections a comprehensive solution rather than a temporary diet aid

Bordone strongly recommends GLP-1s for patients with psoriasis if these conditions apply: A BMI over 30 A BMI over 27 with obstructive sleep apnea High blood pressure Abnormal cholesterol High fasting glucose Insulin resistance Prediabetes Ive seen firsthand how these medications can positively impact patients who have both psoriasis and metabolic conditions like obesity or type 2 diabetes, says Kopelman, who coordinates with her patients primary care providers when she feels a GLP-1 may help

Comorbidities were prevalent